
We had the privilege of hosting an inspiring group of global health leaders at our “The World of HIV: Invisible Battles, Visible Hope” symposium at the Leadership Academy in Bachupally, Hyderabad.
Throughout the day, we heard from experts at Clinton Health Access Initiative (CHAI):
They shared powerful insights on the current HIV/AIDS landscape and aligned on our shared mission: to reduce AIDS‑related deaths by making HIV treatment accessible, affordable, and sustainable for millions worldwide.
Joining us virtually was Elizabeth Cerqueira Murray, MBA, Former Executive Director– Global Patient Solutions & Voluntary License at Gilead Sciences. She highlighted how voluntary licensing of Lenacapavir can dramatically improve treatment access worldwide.
From our side, Deepak Sapra, CEO – API & Services, and Karun Gaur, Global Head – Strategic Projects – APIs, reaffirmed our commitment to tackling unmet healthcare needs and making high‑quality treatments accessible. Dr. Anil Jain, Head of Global Medical Affairs, demystified AIDS—addressing common myths, explaining disease progression, and sharing key steps toward defeating HIV. The energy in the space was palpable people left inspired, informed, and ready to act.
本網站上的任何信息,包括對任何產品或服務的任何提及,均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是,在某些情況下,雷迪博士可自行決定並根據當地法律要求,在存在此類監管豁免的任何地方,提供此類產品的研究數量,以根據《印度專利法》第 107A 條(Bolar 豁免)進行監管提交。購買者應對其各自市場的產品或服務(包括專利情況)進行獨立評估,並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證,包括但不限於適銷性、適用於特定用途和非侵權的保證。